The Science working group aims at improving the industry conditions for Life Science companies in Sweden and support business develpoment
The members are established executives with a strong scientific background.
Members
| Name |
Position |
Company |
|
|
|
| Peter Edman (Chairman) |
CSO |
Swedish Orphan Biovitrum |
| Maris Hartmanis |
Member of the Board |
Vitrolife |
| Stefan Löfås |
Science Director |
GE Healthcare |
| Sverker Ljunghall |
Science Relations |
AstraZeneca |
| Einar Pontén |
CEO |
MerckSequant |
| Per Matsson |
CTO |
Phadia |
| Karin Aase |
WG Coordinator |
SwedenBIO |
Goals
- Intensify Industry-Academia collaboration
- Facilitate public R&D funding for Life Science
- Support initiatives to attract unique research compentences to Sweden
Contact: karin.aase@swedenbio.com